Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
María Cañibano-Pico
Observed names:
Maria Canibano Pico,
Maria Canibano-Pico,
Maria Cañibano-Pico
Institutions:
University of London,
UCL Queen Square Institute of Neurology,
University College London
Observed institutions:
University of London,
UK Dementia Research Institute,
UCL Queen Square Institute of Neurology,
University College London
ORCID:
0009-0008-7080-1221
Observed ORCID:
0009-0008-7080-1221
OpenAlex ID:
A5037401561
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
2024
·
Sarah G Aldous
, Edward J Smith
, et al.
·
Brain
·
73
Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays
2024
·
Christian Landles
, Georgina F Osborne
, et al.
·
Brain Communications
·
24
Lowering the HTT1a transcript as an effective therapy for Huntington’s disease in a knockin mouse model
2026
·
Aikaterini Smaragdi Papadopoulou
, Julia Alterman
, et al.
·
Science Translational Medicine
·
12
Translatable plasma and CSF biomarkers for use in mouse models of Huntington’s disease
2023
·
Marie K Bondulich
, Jemima Phillips
, et al.
·
Brain Communications
·
11
The HTT1a protein initiates HTT aggregation in a knock-in mouse model of Huntington’s disease
2026
·
Aikaterini Smaragdi Papadopoulou
, Christian Landles
, et al.
·
Brain
·
5
A015 Mutant Huntingtin protein levels decrease with CAG repeat expansion: implications for therapeutics and bioassays
2024
·
Christian Landles
, Georgina Osborne
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
2
PDF
D21 Analysis of blood and CSF biomarkers in mouse models of Huntington’s disease
2022
·
Marie K Bondulich
, Lauren M Byrne
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
2
Enhancing the detection of HTT1a with neoepitope antibodies in mouse models of Huntington’s disease
2026
·
Georgina F Osborne
, Edward J Smith
, et al.
·
Brain Communications
·
1
I006 Lowering htt1a with sirnas has more impact on early molecular and histological phenotypes than lowering full-length htt
2024
·
Aikaterini S Papadopoulou
, Christian Landles
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
1
PDF
B005 Characterisation of mouse embryonic fibroblast models of Huntington’s disease and their application as screening tools for therapeutic agents
2024
·
Casandra Gomez-Paredes
, Kirupa Sathasivam
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
PDF
D007 Translatable plasma and CSF biomarkers for use in mouse models of Huntington’s disease
2024
·
Marie Bondulich
, Lauren Byrne
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
PDF
A002 A CAG repeat threshold for therapeutics targeting somatic instability in mouse models of Huntington’s disease
2024
·
Sarah G Aldous
, Edward J Smith
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
PDF
Show more works
View as search
Works count:
12
Citation count:
131
H-index:
5
I10-index:
4
Year
Topic
Type